The question of whether enhanced memory T cell responses are simply due to an increased frequency of specific cells or also to an improved response at the single cell level is widely debated. In this study, we analyzed T cell receptor (TCR) transgenic memory T cells and bona fide memory T cells isolated from virally infected normal mice using the tetramer technology. We found that memory T cells are qualitatively different from naive T cells due to a developmentally regulated rearrangement of the topology of the signaling machinery. In naive cytotoxic T cells, only a few CD8 molecules are associated with Lck and the kinase is homogeneously distributed inside the cell. However, in vivo priming of naive T cells induces the targeting of Lck to the CD8 coreceptor in the cell membrane and the consequent organization of a more efficient TCR signaling machinery in effector and memory cells.
Skip Nav Destination
Article navigation
17 May 1999
Article|
May 17 1999
Developmental Regulation of Lck Targeting to the CD8 Coreceptor Controls Signaling in Naive and Memory T Cells
Martin F. Bachmann,
Martin F. Bachmann
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Awen Gallimore,
Awen Gallimore
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Susanne Linkert,
Susanne Linkert
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Vincenzo Cerundolo,
Vincenzo Cerundolo
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Antonio Lanzavecchia,
Antonio Lanzavecchia
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Manfred Kopf,
Manfred Kopf
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Antonella Viola
Antonella Viola
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Martin F. Bachmann
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Awen Gallimore
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Susanne Linkert
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Vincenzo Cerundolo
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Antonio Lanzavecchia
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Manfred Kopf
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Antonella Viola
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the ‡Department of Molecular Immunology, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Address correspondence to Martin F. Bachmann, Basel Institute for Immunology, Grenzacherstrasse 487, CH-4005 Basel, Switzerland. Phone: 41-61-605-1228; Fax: 41-61-605-1364; E-mail: [email protected]
The Basel Institute for Immunology was founded and is supported by F. Hoffmann-La Roche, Basel, Switzerland.
Received:
November 18 1998
Revision Received:
March 16 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1999
J Exp Med (1999) 189 (10): 1521–1530.
Article history
Received:
November 18 1998
Revision Received:
March 16 1999
Citation
Martin F. Bachmann, Awen Gallimore, Susanne Linkert, Vincenzo Cerundolo, Antonio Lanzavecchia, Manfred Kopf, Antonella Viola; Developmental Regulation of Lck Targeting to the CD8 Coreceptor Controls Signaling in Naive and Memory T Cells . J Exp Med 17 May 1999; 189 (10): 1521–1530. doi: https://doi.org/10.1084/jem.189.10.1521
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement